{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T12:12:32Z","timestamp":1695989552966},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1752-1947-4-269","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:20:10Z","timestamp":1281622810000},"source":"Crossref","is-referenced-by-count":4,"title":["Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report"],"prefix":"10.1186","volume":"4","author":[{"given":"Antonino M","family":"Previtera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S0140-6736(89)92327-1","volume":"1","author":"M Gent","year":"1989","unstructured":"Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AG: The Canadian American Ticlopidine Study (CATS) in the thromboembolic stroke. Lancet. 1989, 1: 1215-1220. 10.1016\/S0140-6736(89)92327-1.","journal-title":"Lancet"},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM198908243210804","volume":"321","author":"WK Hass","year":"1989","unstructured":"Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, Kamm B: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989, 321: 501-507. 10.1056\/NEJM198908243210804.","journal-title":"N Engl J Med"},{"key":"1226_CR3","unstructured":"SPREAD Stroke Prevention And Educational Awerness Diffusion - V Edizione 2007 - Ictus cerebrale: linee guida italiane di prevenzione e trattamento, 319."},{"key":"1226_CR4","first-page":"1441","volume":"163","author":"F Paradiso-Hardy","year":"2000","unstructured":"Paradiso-Hardy F, Angelo MC, Lanctot KL, Cohen EA: Hematologic dyscrasia associated with ticlopidine therapy: evidence for casuality. CMAJ. 2000, 163: 1441-1448.","journal-title":"CMAJ"},{"key":"1226_CR5","first-page":"713","volume":"10","author":"A Grieco","year":"1998","unstructured":"Grieco A, Vecchio FM, Greco AV, Gasbarrini G: Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature. Eur J Gastroenterol Hepatol. 1998, 10: 713-715.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1226_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2002.05642.x","volume":"97","author":"L Alberti","year":"2002","unstructured":"Alberti L, Alberti-Flor JJ: Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids (letter). Am J Gastroenterol. 2002, 97: 107-10.1111\/j.1572-0241.2002.05642.x.","journal-title":"Am J Gastroenterol"},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1592\/phco.19.11.1006.31567","volume":"18","author":"Cj Kubin","year":"1999","unstructured":"Kubin Cj, Shermann O, Hussain KB, Feinman L: Delayed onset ticlopidine induced cholestatic jaundice. Pharmacotherapy. 1999, 18: 1006-1010. 10.1592\/phco.19.11.1006.31567.","journal-title":"Pharmacotherapy"},{"key":"1226_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<260::AID-AJH16>3.0.CO;2-5","volume":"59","author":"C Celyan","year":"1998","unstructured":"Celyan C, Kirimli O, Akarsu M, Under B, Guneri S: Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting. Am J Hematol. 1998, 59: 260-264.","journal-title":"Am J Hematol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-4-269\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-4-269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:40:06Z","timestamp":1548117606000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-4-269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-4-269","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]},"article-number":"269"}}